Charles River Laboratories (CRL) provides products and services to help expedite the discovery, early-stage development, and safe manufacturing of novel drugs and therapeutics. CRL plays an essential role in delivering therapeutic breakthroughs that have positively transformed the quality of life for people in Canada and around the globe. It focuses on activities affecting the medical research community both nationally and internationally. Through its engagement, CRL is seeking to ensure that the Government of Canada understands the critical role it plays in ensuring the health and safety of Canadians and its business, economic, and scientific impact in Canada's healthcare ecosystem.
David Leroux-Petersen, Corporate Vice-President
Date de la fin du dernier exercice financier complet : 2022-12-31
Institution gouvernementale | Financement reçu au cours du dernier exercice financier | Financement attendu pendant l'exercice financier en cours |
---|---|---|
Quebec Provincial Government (Sectorial committee -Pharmabio Developpement) | 50 425,20 $ | Non |
Adresse :
251 Ballardvale Street
Wilmington, MA 01887
États-Unis d'Amérique
Numéro de téléphone :
781-222-6000
Laboratoires Charles River / Charles River Laboratories n'est pas une filiale d'une société mère.
Laboratoires Charles River / Charles River Laboratories ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement